TLP
Tri Locum Partners’s Axsome Therapeutics AXSM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.5M | Buy |
157,861
+56,621
| +56% | +$5.91M | 5% | 10 |
|
2025
Q1 | $11.8M | Sell |
101,240
-148,529
| -59% | -$17.3M | 6.06% | 7 |
|
2024
Q4 | $21.1M | Buy |
249,769
+158,048
| +172% | +$13.4M | 4.38% | 7 |
|
2024
Q3 | $8.24M | Sell |
91,721
-214,792
| -70% | -$19.3M | 1.97% | 17 |
|
2024
Q2 | $24.7M | Buy |
306,513
+203,802
| +198% | +$16.4M | 6.24% | 6 |
|
2024
Q1 | $8.2M | Sell |
102,711
-28,027
| -21% | -$2.24M | 2.84% | 16 |
|
2023
Q4 | $10.4M | Sell |
130,738
-11,772
| -8% | -$937K | 4.76% | 9 |
|
2023
Q3 | $9.96M | Sell |
142,510
-57,570
| -29% | -$4.02M | 3.18% | 10 |
|
2023
Q2 | $14.4M | Buy |
200,080
+50,875
| +34% | +$3.66M | 5.34% | 6 |
|
2023
Q1 | $9.2M | Sell |
149,205
-50,849
| -25% | -$3.14M | 2.8% | 12 |
|
2022
Q4 | $15.4M | Buy |
+200,054
| New | +$15.4M | 6.24% | 4 |
|